Cristina Puchades

Technology Transfer Intern at UCSF Innovation Ventures
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US
Languages
  • English Full professional proficiency
  • Spanish Native or bilingual proficiency
  • German Full professional proficiency
  • Catalan Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Technology Transfer Intern
      • Sep 2022 - Present

      Evaluate novel UCSF inventions in immune-oncology, cell therapy, genomics, and small drug molecules, to identify promising start-up opportunities in therapeutics, diagnostics and medical devices: interview inventors and KOLs, write market assessment reports for internal priority ranking, discuss IP opportunities with patent lawyers and prepare pitch decks for licensing opportunities. Evaluate novel UCSF inventions in immune-oncology, cell therapy, genomics, and small drug molecules, to identify promising start-up opportunities in therapeutics, diagnostics and medical devices: interview inventors and KOLs, write market assessment reports for internal priority ranking, discuss IP opportunities with patent lawyers and prepare pitch decks for licensing opportunities.

    • Spain
    • Biotechnology Research
    • 1 - 100 Employee
    • Life Sciences Consultant
      • Jan 2023 - Present

      Review and evaluation of pitch decks from innovative life science companies that seek investment through crowdfunding campaigns at Capital Cell Review and evaluation of pitch decks from innovative life science companies that seek investment through crowdfunding campaigns at Capital Cell

    • United States
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Research Fellow
      • Dec 2019 - Present

      Structure-function studies of the TMEM16 family of membrane ion channels and lipid scramblases: Combined cryogenic Electron Microscopy (cryo-EM) with biochemical and cell biological tools to determine the binding site and mechanism of action of potent TMEM16 inhibitors with therapeutic potential against cancer and COVID-19.

    • Cryo-EM Team Leader at QBI Coronavirus Research Group (QCRG)
      • Mar 2020 - Aug 2020

      Managed a 15-person team as part of an institute-wide emergency consortium during the COVID19 lockdown: established SOPs, mentored trainees, coordinated data collection, transferred promising samples to the appropriate teams, and reported to upper management

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Pro-bono Strategy Consultant
      • Sep 2022 - Dec 2022

      Worked in an interdisciplinary team to assess the competitive landscape and commercial potential of an artificial intelligence start-up for drug development, and helped develop go-to-market strategies Worked in an interdisciplinary team to assess the competitive landscape and commercial potential of an artificial intelligence start-up for drug development, and helped develop go-to-market strategies

    • United States
    • Research Services
    • 700 & Above Employee
    • Graduate Student
      • Aug 2014 - Oct 2019

      Elucidated the mechanism of action of ATP-dependent protein quality control complexes and its implications for neurodegenerative diseases

    • Teaching Assistant
      • Jan 2017 - Apr 2017

    • Biotechnology Research
    • 1 - 100 Employee
    • Research Technician
      • Jan 2012 - Oct 2013

      Developed a method to study the effect of drug candidates on the main surface antigen of influenza, Hemagglutinin, by Hydrogen Deuterium Exchange-Mass Spectrometry (HDX-MS). Established a molecular marker for broad neutralization to assess the pharmacological potential of drug candidates, such as monoclonal antibodies and synthetic cyclic peptides, at early stages of drug discovery

    • Trainee
      • Oct 2011 - Dec 2011

      Biophysical studies of prophylactic Anti-Influenza Monoclonal Antibody cocktails to determine their conformational stability, cross interaction propensity and aggregation tendency.

    • Summer Internship
      • Jul 2010 - Sep 2010

      Whole-mount in situ hybridation: Studied of the effect of different hormonal treatments on gene expression in Arabidopsis thaliana seedlings Whole-mount in situ hybridation: Studied of the effect of different hormonal treatments on gene expression in Arabidopsis thaliana seedlings

Education

  • Scripps Research
    Doctor of Philosophy - PhD, Biochemistry
    2014 - 2019
  • Universitat Politècnica de València (UPV)
    Bachelor of Science - BS, Biotechnology
    2007 - 2011

Community

You need to have a working account to view this content. Click here to join now